495 related articles for article (PubMed ID: 15707890)
1. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
Boire A; Covic L; Agarwal A; Jacques S; Sherifi S; Kuliopulos A
Cell; 2005 Feb; 120(3):303-13. PubMed ID: 15707890
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
3. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.
Kamath L; Meydani A; Foss F; Kuliopulos A
Cancer Res; 2001 Aug; 61(15):5933-40. PubMed ID: 11479236
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas.
Zhang Y; Zhan H; Xu W; Yuan Z; Lu P; Zhan L; Li Q
Pathol Res Pract; 2011 Jan; 207(1):24-9. PubMed ID: 21087829
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.
Fujimoto D; Hirono Y; Goi T; Katayama K; Yamaguchi A
Anticancer Res; 2008; 28(2A):847-54. PubMed ID: 18507028
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.
Arora P; Ricks TK; Trejo J
J Cell Sci; 2007 Mar; 120(Pt 6):921-8. PubMed ID: 17344429
[TBL] [Abstract][Full Text] [Related]
7. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.
Du X; Wang S; Lu J; Cao Y; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Li J
Jpn J Clin Oncol; 2011 Sep; 41(9):1086-93. PubMed ID: 21835828
[TBL] [Abstract][Full Text] [Related]
8. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.
Souazé F; Dupouy S; Viardot-Foucault V; Bruyneel E; Attoub S; Gespach C; Gompel A; Forgez P
Cancer Res; 2006 Jun; 66(12):6243-9. PubMed ID: 16778199
[TBL] [Abstract][Full Text] [Related]
9. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
10. Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness.
Yin YJ; Salah Z; Grisaru-Granovsky S; Cohen I; Even-Ram SC; Maoz M; Uziely B; Peretz T; Bar-Shavit R
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):940-4. PubMed ID: 12637343
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases target protease-activated receptors on the tumor cell surface.
Pei D
Cancer Cell; 2005 Mar; 7(3):207-8. PubMed ID: 15766657
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
[TBL] [Abstract][Full Text] [Related]
13. Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1.
Diaz J; Aranda E; Henriquez S; Quezada M; Espinoza E; Bravo ML; Oliva B; Lange S; Villalon M; Jones M; Brosens JJ; Kato S; Cuello MA; Knutson TP; Lange CA; Leyton L; Owen GI
J Endocrinol; 2012 Aug; 214(2):165-75. PubMed ID: 22593082
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
[TBL] [Abstract][Full Text] [Related]
15. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
16. HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
Mansfield L; Subramanian A; Devalia H; Jiang W; Newbold RF; Mokbel K
Anticancer Res; 2007; 27(4B):2265-8. PubMed ID: 17695512
[TBL] [Abstract][Full Text] [Related]
17. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.
Berno V; Porrini D; Castiglioni F; Campiglio M; Casalini P; Pupa SM; Balsari A; Ménard S; Tagliabue E
Endocr Relat Cancer; 2005 Jun; 12(2):393-406. PubMed ID: 15947111
[TBL] [Abstract][Full Text] [Related]
18. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells.
Nguyen N; Kuliopulos A; Graham RA; Covic L
Cancer Res; 2006 Mar; 66(5):2658-65. PubMed ID: 16510585
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.
Goerge T; Barg A; Schnaeker EM; Poppelmann B; Shpacovitch V; Rattenholl A; Maaser C; Luger TA; Steinhoff M; Schneider SW
Cancer Res; 2006 Aug; 66(15):7766-74. PubMed ID: 16885380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
